Arena Pharma (ARNA) options active into FDA vote
Tweet Send to a Friend
Arena Pharmaceuticals (Nasdaq: ARNA) is recently down 47c to $3.68. ARNA shares sold of 35% on September 14 on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


